Valuation check: EUDAW's ROE is 65.17%, above the sector sector average of -5.68%.
Get informed when a big investor buys or sells
+ Follow65.17%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Euda Health Holdings Limited - Warrants (17/11/2027)'s return on equity stands at 65.17%. That is above the sector sector average of -5.68%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Euda Health Holdings Limited - Warrants (17/11/2027) sits higher the its sector benchmark (-5.68%) with a ROE of 65.17%. That is roughly 1246.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 65.17% for Euda Health Holdings Limited - Warrants (17/11/2027) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Euda Health Holdings Limited - Warrants (17/11/2027)'s ROE evolved across reporting periods, while the comparison chart places EUDAW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.